Tianjin Zhong Xin Pharmaceutical Group Corporation is engaged in manufacturing medicine and pharmaceutical raw materials. The company offers Chinese patent medicines, Chinese medicinal materials, pharmaceutical raw materials and western medicines, bioengineering drugs and nutritious & health products among others. Tianjin Zhong Xin Pharmaceutical key products are Suxiao Jiuxin Wan used in heart disease treatment; Huoxiang Zhengqi Ruan Jiaonang used for treatments in intestines and stomach diseases; Zilong Jin Pian used for treatment of cancer; Jinq Jiangtang Pian used for treatment of diabetes; Weichang An Wan for curing the deceases such as diarrhea; Biqi Jiaonang used for treatment of rheumatism; a-2b Interferon used in increasing immunity; Gliclazide; and Te Zi She Fu used for diminishing inflammation and other medicines. The company has built up wholesale and retail system in various areas of Tianjin Municipality, with a marketing network extending to more than 30 countries and regions as well as all across China through joint venture with pharmaceutical enterprises such as Glax Smithkline America, Teva Israel, Baxter America and Shinpoong Seoul Korea. Tianjin Zhong Xin Pharmaceutical Group Corporation was incorporated in 1992.
No.17 Baidi Road,Nankai District
Tianjin; Tianjin; Postal Code: 300193
Contact Details: Purchase the Tianjin Zhongxin Pharmaceutical Group Corporation Limited report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service